Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof

Details for Australian Patent Application No. 2009215804 (hide)

Owner Amgen Inc.

Inventors Oliner, Jonathan D.; Boone, Thomas C.

Agent Shelston IP

Pub. Number AU-A-2009215804

PCT Pub. Number WO2009/105269

Priority 61/139,361 19.12.08 US; 61/061,943 16.06.08 US; 61/066,632 20.02.08 US

Filing date 20 February 2009

Wipo publication date 27 August 2009

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

26 August 2010 PCT application entered the National Phase

  PCT publication WO2009/105269 Priority application(s): WO2009/105269

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215805-Separation of hydrogen from hydrocarbons utilizing zeolitic imidazolate framework materials

2009215799-Method for early determination of recurrence after therapy for prostate cancer